Brightseed is an AI-driven data and biosciences pioneer on a mission to illuminate nature to restore human health.
Brightseed was founded by a diverse group of passionate individuals dedicated to addressing the world’s most pressing health challenges with solutions from the natural world.
From agricultural crops to specialized ingredients to pharmaceuticals, we are committed to advancing health by building an ecosystem that delivers the benefits of bioactives to consumers.
Brightseed exists to change the way we approach health—and to shift us from a reactive system to a proactive one. Through science, we unlock natural solutions across the health continuum that change the lives of people around the world.
As health’s unsung heroes, bioactives offer the key to ending the burdens of chronic diseases. Because of this, Brightseed partners with industry leaders to commercialize and communicate the power of bioactives as we build the next era of human health.
We are scientists, technologists, metabolomics experts, biologists, natural product chemists, doctors, process engineers, supply chain builders, and business leaders. We are also musicians, athletes, mothers, fathers, artists, writers, and plant fanatics—all working together to advance the knowledge of plants and their impact on humankind.
Jim Flatt, PhD
Co-Founder and CEO
Co-Founder and COO
Lee Chae, PhD
Co-Founder and CTO
Chief People Officer
Jan Willem Van Klinken
SVP Medical, Scientific & Regulatory Affairs
VP of Marketing
Head of Finance
Investor, Horizons Ventures
Former President of Yoplait and Häagen-Dazs, General Mills
Former Founder and CEO, OpenTable, Former Chairman, GrubHub, Investor, S2G
Former CMO, Abbott Nutrition
Investor, Temasek International
Bernhard van Lengerich
Former CSO, General Mills
Dariush Mozaffarian, MD, DrPH
Cardiologist & Dean of the School of Nutrition, Tufts University
Former Chairman & CEO, Pepsico
Ryan D. Shadrick Wilson
CEO and Founder Boardwalk Collective
Walter Robb, PhD
Former CO-CEO, Whole Foods
Explore how Forager can enhance your portfolio and innovation pipeline.
Press & Features